Sahil A Parikh
Sahil A Parikh
Dominik M Wiktor,Stephen W Waldo,Ehrin J Armstrong
Dominik M Wiktor
Current-generation coronary drug-eluting stents are associated with low rates of restenosis and target lesion revascularization. However, several mechanisms of stent failure remain clinically important. Stent fracture may occur in areas of ...
Kenta Nakamura,John H Keating,Elazer Reuven Edelman
Kenta Nakamura
Contemporary endovascular stents are the product of an iterative design and development process that leverages evolving concepts in vascular biology and engineering. This article reviews how insights into vascular pathophysiology, materials...
Alexis Powell,Vikram S Kashyap
Alexis Powell
Endovascular treatment for aortic abnormality is an excellent alternative option for patients who are not good candidates for conventional open surgery. Although the technique of placing endovascular stent grafts has evolved since the first...
Design and Comparison of Large Vessel Stents: Balloon Expandable and Self-Expanding Peripheral Arterial Stents [0.03%]
大规模血管支架的设计及比较：外周动脉球囊扩张和自膨式支架
Sandeep M Patel,Jun Li,Sahil A Parikh
Sandeep M Patel
Endovascular stenting has evolved over the last 50 years since its inception into the framework of management of vascular atherosclerotic disease. Stent design has evolved as lesion complexity has increased. Nevertheless, certain first prin...
Davide Capodanno
Davide Capodanno
Bioresorbable scaffolds (BRS) have been engineered to eliminate the theoretic stimulus to late coronary events, a caveat of conventional metallic drug-eluting stents (DESs). Outcome benefits of BRSs over current-generation DESs are expected...
Mary Beth Kossuth,Laura E L Perkins,Richard J Rapoza
Mary Beth Kossuth
The concept for a bioresorbable vascular scaffold combines the best features of the first 3 generations of percutaneous coronary intervention (namely), balloon angioplasty, bare metallic stents, and drug-eluting stents, into a single device...
Contemporary Drug-Eluting Stent Platforms: Design, Safety, and Clinical Efficacy [0.03%]
当代药物洗脱支架平台：设计、安全性及临床疗效
Ramon A Partida,Robert W Yeh
Ramon A Partida
First-generation drug-eluting stents significantly improved treatment of coronary disease, decreasing rates of revascularization. This was offset by high rates of late adverse events, driven primarily by stent thrombosis. Research and desig...
Anwer Habib,Aloke Virmani Finn
Anwer Habib
Cardiovascular disease is a leading cause of death and disability worldwide. Current treatment strategies aimed at treating the symptoms and consequences of obstructive vascular disease have embraced both optimal medical therapy and cathete...
Abraham Rami Tzafriri,Elazer Reuven Edelman
Abraham Rami Tzafriri
Endovascular drug delivery continues to revolutionize the treatment of atherosclerosis in coronary and peripheral vasculature. The key has been to identify biologic agents that can counter the hyperplastic tissue responses to device expansi...